Published in Postgrad Med J on May 01, 1996
Current methods for detecting antibodies against erythropoietin and other recombinant proteins. Clin Diagn Lab Immunol (2005) 0.84
Antistreptokinase antibodies: implications for thrombolysis in a region with endemic streptococcal infection. J Clin Pathol (2005) 0.78
Antistreptokinase antibodies and the response to thrombolysis with streptokinase in patients with acute ST elevation myocardial infarction. Heart Asia (2012) 0.75
Immunoglobulin response to intravenous streptokinase in acute myocardial infarction. Br Heart J (1991) 2.12
IgG1 is the predominant subclass of in vivo- and in vitro- produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells. J Clin Immunol (1983) 1.67
Why do patients develop reactions to streptokinase? Clin Exp Immunol (1993) 1.23
The significance of anti-streptokinase antibodies. Clin Exp Immunol (1994) 0.99
Proceedings: A controlled study of the diuretic and natriuretic properties of perhexiline maleate in normal human volunteers. Postgrad Med J (1973) 0.98
Rapid detection and quantitation of precipitating streptokinase-antibodies. Thromb Diath Haemorrh (1974) 0.97
Recommendations on blood pressure measurement. Br Med J (Clin Res Ed) (1986) 4.97
Practolol in treatment of angina pectoris. A double-blind trial. Br Med J (1970) 3.43
A milestone for myocardial infarction. BMJ (1988) 3.42
Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ (2000) 3.37
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med (2000) 3.00
Results of a general hospital coronary care service. Br Med J (1968) 2.70
Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J (1970) 2.29
Natural history and clinical significance of arrhythmias after acute cardiac infarction. Br Heart J (1967) 2.13
Immunoglobulin response to intravenous streptokinase in acute myocardial infarction. Br Heart J (1991) 2.12
Coronary care for myocardial infarction in diabetics. Lancet (1974) 2.12
Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect. Thorax (1984) 2.07
Proteinuria with streptokinase. Lancet (1993) 2.01
Continuous recording of direct arterial pressure and electrocardiogram in unrestricted man. Br Med J (1972) 1.91
COPD exacerbations . 2: aetiology. Thorax (2006) 1.90
Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax (2011) 1.89
Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis. Thorax (1984) 1.82
A study of plasma proteins in the sol phase of sputum from patients with chronic bronchitis. Thorax (1979) 1.79
Renal pathological findings in infective endocarditis. Nephrol Dial Transplant (2000) 1.74
High-resolution computed tomography scanning in alpha1-antitrypsin deficiency: relationship to lung function and health status. Eur Respir J (2001) 1.71
Alpha,-antitrypsin and leukocyte elastase in infected and noninfected sputum. Am Rev Respir Dis (1979) 1.69
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J (2001) 1.67
Median nerve palsy--a complication of brachial artery cannulation. Postgrad Med J (1976) 1.65
Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax (2000) 1.65
Busulphan lung. Thorax (1969) 1.63
Rate of progression of lung function impairment in alpha1-antitrypsin deficiency. Eur Respir J (2009) 1.61
COPD: current therapeutic interventions and future approaches. Eur Respir J (2005) 1.61
Acute aortitis and aortic incompetence due to systemic rheumatological disorders. Int J Cardiol (1991) 1.59
Direct arterial pressure, heart rate and electrocardiogram during human coitus. J Reprod Fertil (1974) 1.56
Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis. Thorax (2009) 1.55
Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax (2005) 1.55
The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med (1999) 1.54
Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J (2000) 1.50
Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol (1991) 1.50
Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability. Lancet (1979) 1.50
Some aspects of the arterial response to venous occlusion in man. Clin Sci (Lond) (1983) 1.49
Use of opposing reflex stimuli and heart rate variability to examine the effects of lipophilic and hydrophilic beta-blockers on human cardiac vagal control. Clin Sci (Lond) (1999) 1.47
The vitamin D axis in the lung: a key role for vitamin D-binding protein. Thorax (2010) 1.46
Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med (1999) 1.45
Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Eur Respir J (2009) 1.41
Identification of a novel antigen from Staphylococcus epidermidis. FEMS Immunol Med Microbiol (2000) 1.40
Sputum and serum pharmacokinetics of loracarbef (LY163892) in patients with chronic bronchial sepsis. J Antimicrob Chemother (1994) 1.39
Dental prophylaxis for endocarditis. Lancet (1992) 1.39
Continuous recording of direct arterial pressure in unrestricted patients. Its role in the diagnosis and management of high blood pressure. Circulation (1975) 1.37
Felodipine, blood pressure, and cardiovascular reflexes in hypertensive humans. Hypertension (1986) 1.36
The straight back syndrome. Q J Med (1980) 1.35
Proteolytic enzymes, their inhibitors and lung diseases. Clin Sci (Lond) (1983) 1.35
Felodipine in hypertension. Eur J Clin Pharmacol (1985) 1.32
The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils. J Biol Chem (1992) 1.32
Acute myocardial infarction in Asians and whites in Birmingham. Br Med J (Clin Res Ed) (1985) 1.32
Survival after acute myocardial infarction in Asian and white patients in Birmingham. Br Heart J (1995) 1.32
The pattern of onset and spontaneous cessation of atrial fibrillation in man. Circulation (1970) 1.30
Cathepsin B-like cysteine proteinase activity in sputum and immunohistologic identification of cathepsin B in alveolar macrophages. Am Rev Respir Dis (1983) 1.29
Coronary artery disease in Asians in Birmingham. Br Heart J (1984) 1.29
Leukotriene B4. Int J Biochem Cell Biol (1998) 1.28
Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax (2001) 1.27
Cardiac involvement in secondary haemochromatosis: a catheter biopsy study and analysis of myocardium. Cardiovasc Res (1980) 1.26
Critical assessment of diagnostic value of endomyocardial biopsy. Assessment of cardiac biopsy. Br Heart J (1978) 1.26
Acquired pulmonary stenosis. Thorax (1970) 1.26
Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet (1989) 1.25
Eligibility for thrombolytic therapy in acute myocardial infarction. Lancet (1987) 1.25
Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency. Thorax (2006) 1.24
Predictors of mortality in alpha1-antitrypsin deficiency. Thorax (2003) 1.24
Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med (2001) 1.24
Why do patients develop reactions to streptokinase? Clin Exp Immunol (1993) 1.23
Myocardial infarction in diabetics. Q J Med (1975) 1.22
Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin Sci (Lond) (1987) 1.22
Sputum sol-phase proteins and elastase activity in patients with cystic fibrosis. Eur J Respir Dis (1984) 1.22
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax (2003) 1.20
Direct arterial pressure, heart rate, and electrocardiogram during cigarette smoking in unrestricted patients. Am Heart J (1975) 1.20
Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency. Eur Respir J (2000) 1.19
The Birmingham blood pressure school study. Postgrad Med J (1983) 1.19
Letter: Failure of "adequate" penicillin therapy to prevent bacterial endocarditis after tooth extraction. Lancet (1974) 1.19
Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation. Thorax (1986) 1.19
Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med (1996) 1.19
Influence of racial origin on admission rates of patients with suspected myocardial infarction in Birmingham. Br Heart J (1991) 1.17
Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. Lancet (1972) 1.17
Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax (2002) 1.16
Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet (1987) 1.15
Cellular immunity in congestive cardiomyopathy. The normal cellular immune response. Br Heart J (1985) 1.15
Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax (2004) 1.15
Effect of corticosteroids on sputum sol-phase protease inhibitors in chronic obstructive pulmonary disease. Thorax (1982) 1.15
Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction. Br Heart J (1984) 1.14
Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax (2003) 1.14
Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo. Br Heart J (1985) 1.13
Simple method for quantifying viable bacterial numbers in sputum. J Clin Pathol (1995) 1.13
Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction. Lancet (1970) 1.13
Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state. Thorax (1984) 1.13
Serum derived protease inhibitors and leucocyte elastase in sputum and the effect of infection. Bull Eur Physiopathol Respir (1980) 1.12
Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8. Thorax (2002) 1.11
The effect of nifedipine on arterial pressure and reflex cardiac control. Circulation (1983) 1.10
Measurement of soluble proteins in lung secretions. Thorax (1984) 1.10
Beta-adrenergic blockade in experimental myocardial infarction. Am Heart J (1966) 1.10